REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed May 3, 2006
Insider Transaction Report
Form 4
McIntosh David M
Director
Transactions
- Award
Stock option (right to buy)
2005-12-08+125,000→ 125,000 totalExercise: $0.80Exp: 2014-04-20→ Common stock (125,000 underlying) - Award
Stock option (right to buy)
2005-09-12+20,000→ 20,000 totalExercise: $3.00From: 2006-09-12Exp: 2015-09-12→ Common stock (20,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2005-12-08−125,000→ 0 totalExercise: $0.24Exp: 2014-04-20→ Common stock (125,000 underlying) - Award
Stock option (right to buy)
2006-05-01+20,000→ 20,000 totalExercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common stock (20,000 underlying)
Footnotes (2)
- [F1]The options vest and become exercisable as to 30% of the options on April 20, 2005; another 30% of the options on April 20, 2006; and the remaining 40% of the options on April 20, 2007.
- [F2]The transaction involved an amendment of outstanding options to change the exercise price with respect to 125,000 options from $0.24 to $0.80, resulting in the deemed cancellation of the original options and the grant of replacement options with the same vesting and exercisability terms as the cancelled options.